Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Capital Expenditures (2020 - 2025)

SOPHiA GENETICS's Capital Expenditures history spans 6 years, with the latest figure at -$338000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 492.98% to -$338000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$574000.0, a 135.25% decrease, with the full-year FY2025 number at -$574000.0, down 135.25% from a year prior.
  • Capital Expenditures hit -$338000.0 in Q4 2025 for SOPHiA GENETICS, down from -$106000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for SOPH hit a ceiling of $1.3 million in Q2 2025 and a floor of -$1.9 million in Q4 2022.
  • Historically, Capital Expenditures has averaged -$454600.0 across 5 years, with a median of -$244500.0 in 2021.
  • Biggest five-year swings in Capital Expenditures: crashed 1396.51% in 2021 and later soared 11058.33% in 2025.
  • Tracing SOPH's Capital Expenditures over 5 years: stood at -$151000.0 in 2021, then plummeted by 1172.19% to -$1.9 million in 2022, then soared by 93.49% to -$125000.0 in 2023, then soared by 54.4% to -$57000.0 in 2024, then tumbled by 492.98% to -$338000.0 in 2025.
  • Business Quant data shows Capital Expenditures for SOPH at -$338000.0 in Q4 2025, -$106000.0 in Q3 2025, and $1.3 million in Q2 2025.